Advancing healthcare industry is driving the growth in Global Psychobiotics Market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast & Opportunities, 2026”, the global psychobiotics market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rising number of depression and anxiety cases among the population.
The young population is more inclined toward self-diagnosing and self-medication, and along with the health concerns among the population, the market is anticipated to show robust growth in the future five years. Moreover, easier availability of the psychobiotics in the form of food supplements, nutritional supplements, and special nutrients; the market is bound to experience the anticipated growth in the CAGR in upcoming five years.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Global Psychobiotics Market”
The global psychobiotics market is segmented by type, psychotropic agent, form, distribution channel, application, competitional landscape, and regional distribution. Based on psychotropic agent, the market is further bifurcated into Streptococcus, Lactobacillus, Clostridium, and others. Streptococcus is a genus of bacteria that is gram-positive and belongs to the family of Straptococcaceae. The bacteria are taken in its inactive form and through biotechnological procedures is abetted for the procedure of manufacturing psychobiotics. Bifidobacterium is also a gram-positive anaerobic bacterium that is inhabitant to human gastrointestinal tract. The bacteria are affective in psychological anxiety and stress ailments along with its widely pronounced functions in digestion.
Based on type, the market is further segmented into food supplements, nutritional supplements, specialty nutrients, and infant formula. Nutritional supplements are anticipated to hold the largest revenue shares of the market and assert its dominance over the market on the account of rapidly growing number of consumers inclined toward self-medication. The consumers are eagerly adapting the psychobiotics as a nutritional supplement for healthy brain. Large population is suffering from depression, stress and anxiety. The tendency of self-diagnosing and self-medication is very active among the young population and thus they are aiding to the growth of the global psychobiotics market in the upcoming five years forecast, until 2026.
Holding the major shares of the global psychobiotics market are Innovix Labs, Bened Biomedical Co., Ltd, Nutrimmun GmbH, Kerry Group Plc., Sabinsa Corporation, Lallemand Health Solutions Inc., DuPont de Nemours, Inc., Uplift Food Pty Ltd., Nature’s Bounty Co. Ltd., BioGaia Group, The Life Extension Foundation, Lifted Naturals, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through psychobiotics. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7678
Customers can also request for 10% free customization on this report.
“North America is anticipated to be the most volatile and most promising market in the future five years. The region consists of the United States and Canada likewise major economies that support excellent healthcare within the country and the presence of multiple market players that hold major shares of the market are other major factors that is expected to support the growth of the market too. Moreover, the consumers of the United States are accounting to maximum number of consumers along with the rapidly growing health-conscious consumers. Asia Pacific may also register itself as a self-reliant market in the next five years on the account of rapidly evolving healthcare industry in the region as well as rapidly increasing cases of depression and anxiety,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global psychobiotics and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global psychobiotics market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017